Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Mallinckrodt Plc Ordinary Share (MNK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
How These Healthcare Stocks are Faring? -- Pfizer, Zoetis, Mallinckrodt, and Patheon

Stock-Callers.com revisits the Healthcare sector, which is an aggregation and integration of sectors within the economic system that provides goods and services to treat patients with curative, preventive,...

ZTS : 62.61 (+0.05%)
MNK : 43.28 (+5.56%)
PFE : 32.14 (-0.06%)
PTHN : 34.55 (-0.17%)
InvestorsObserver releases covered-call reports for Archer-Daniels-Midland, Bunge, Lowes, Mallinckrodt Public Limited Company and Take-Two Interactive

InvestorsObserver issues critical PriceWatch Alerts for ADM, BG, LOW, MNK, and TTWO.

BG : 82.17 (-1.26%)
LOW : 80.91 (-0.52%)
ADM : 42.45 (-0.40%)
MNK : 43.28 (+5.56%)
TTWO : 77.07 (-1.86%)
First Patient Enrolled in Mallinckrodt Phase 4 Trial of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, today confirmed enrollment of the first patient in the company's Phase 4 pilot study assessing the efficacy of H.P. Acthar®...

MNK : 43.28 (+5.56%)
Mallinckrodt To Present At Goldman Sachs 38th Annual Global Healthcare Conference

Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading global specialty pharmaceutical company, will present on Tuesday, June 13, 2017, at the Goldman Sachs 38th Annual Global Healthcare Conference at the...

MNK : 43.28 (+5.56%)
Mallinckrodt Earnings, Revenues Beat Estimates in Q1

Mallinckrodt Public Limited Company (MNK) reported first-quarter 2017 results wherein both sales and earnings beat expectations.

GALE : 0.56 (-3.45%)
VVUS : 1.13 (+0.89%)
MDCO : 39.14 (-0.63%)
MNK : 43.28 (+5.56%)
Mallinckrodt (MNK) Tops Q1 Earnings, Sales

Mallinckrodt beats on earnings and sales in the first quarter.

MNK : 43.28 (+5.56%)
Mallinckrodt plc Reports Earnings Results for First Quarter of Fiscal 2017

Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, today reported results for the first quarter fiscal 2017. Unless otherwise noted, all comparisons of the first quarter fiscal...

MNK : 43.28 (+5.56%)
First Patient Enrolled in Mallinckrodt Phase 2 Trial of StrataGraft® Regenerative Skin Tissue

Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, today confirmed enrollment of the first patient in the company's Phase 2 study assessing the safety, tolerability and efficacy...

MNK : 43.28 (+5.56%)
What's in Store for Mallinckrodt (MNK) This Earnings Season?

Mallinckrodt plc (MNK) is set to report first-quarter fiscal 2017 results on May 8.

HZNP : 10.20 (+2.31%)
MDCO : 39.14 (-0.63%)
FGEN : 27.25 (+0.37%)
MNK : 43.28 (+5.56%)
Mallinckrodt To Present At Deutsche Bank 42nd Annual Healthcare Conference

Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading global specialty pharmaceutical company, will present on Wednesday, May 3, 2017, at the Deutsche Bank 42nd Annual Healthcare Conference at the InterContinental...

MNK : 43.28 (+5.56%)
DB : 18.46 (-2.07%)
Generic Drugs Stocks on Investors' Radar -- Zoetis, Mallinckrodt, Akorn, and MYOS RENS Technology

Companies in the Generic Drugs space develop prescription and over-the-counter drug products that are used to prevent or treat illnesses in humans or animals. Industry operators are not significantly engaged...

MYOS : 2.15 (-3.59%)
ZTS : 62.61 (+0.05%)
MNK : 43.28 (+5.56%)
AKRX : 33.21 (-0.09%)
Mallinckrodt to pay $35M in deal to end feds' opioid probe

TRENTON, N.J. (AP) — A top maker of brand-name and generic narcotic painkillers has agreed to pay the U.S. government $35 million to resolve a probe of its distribution of those drugs.

MNK : 43.28 (+5.56%)
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Mallinckrodt plc of Class Action Lawsuit and Upcoming Deadline - MNK

NEW YORK, NY / ACCESSWIRE / March 24, 2017 / Pomerantz LLP announces that a class action lawsuit has been filed against Mallinckrodt plc ("Mallinckrodt" or the "Company") (NYSE: MNK) and certain of its...

MNK : 43.28 (+5.56%)
MNK DEADLINE: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Mallinckrodt plc and a Lead Plaintiff Deadline of March 27, 2017

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of Columbia on behalf of investors who purchased Mallinckrodt plc (NYSE:MNK) securities...

MNK : 43.28 (+5.56%)
March 27 Deadline Alert: Law Offices of Howard G. Smith Reminds Mallinckrodt Public Limited Company Investors of Upcoming Lead Plaintiff Deadline

Law Offices of Howard G. Smith reminds investors of the upcoming March 27, 2017 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Mallinckrodt...

MNK : 43.28 (+5.56%)
Mallinckrodt plc To Report Earnings Results For First Quarter Of Fiscal 2017

Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading global specialty pharmaceutical company, announced today it will report fiscal 2017 first quarter earnings results for the period of Dec. 31, 2016, to...

MNK : 43.28 (+5.56%)
DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Mallinckrodt Public Limited Company (MNK) & Lead Plaintiff Deadline: March 27, 2017

Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Mallinckrodt Public Limited Company ("Mallinckrodt" or the "Company") (NYSE:MNK)...

MNK : 43.28 (+5.56%)
Sears, Nike and US Bancorp stumble while FedEx, Duluth rise

NEW YORK (AP) — Stocks that moved substantially or traded heavily on Wednesday:

PEG : 44.43 (-0.25%)
PPG : 107.24 (+0.31%)
MNK : 43.28 (+5.56%)
SHLD : 7.78 (-8.25%)
FDX : 194.26 (-0.28%)
DLTH : 19.79 (+2.17%)
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Mallinckrodt plc of Class Action Lawsuit and Upcoming Deadline - MNK

Pomerantz LLP announces that a class action lawsuit has been filed against Mallinckrodt plc ("Mallinckrodt" or the "Company") (NYSE:MNK) and certain of its officers. The class action, filed in United...

MNK : 43.28 (+5.56%)
Mallinckrodt Completes Sale Of Its Intrathecal Therapy Business To Piramal Enterprises Limited For Approximately $203 Million

Mallinckrodt plc (NYSE: MNK), a leading specialty pharmaceutical company, announced today it has closed the sale of its Intrathecal Therapy business to Piramal Enterprises Limited's subsidiary in the U.K.,...

MNK : 43.28 (+5.56%)

Van Meerten Stock Picks

5 All Time High Large Caps for Momentum Investors
This morning I wanted to find 5 Large Caps that hit All Time Highs that might be of interest to Momentum Investors.
AON -0.31 , BAP -0.87 , BF.B +0.13 , VEEV +5.08 , ROL -0.17
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

Barchart Morning Call

OVERNIGHT MARKETS AND NEWS Jun E-mini S&Ps ( ESM17 -0.19% ) this morning are down -0.09% as prices consolidate following the rally this week to Thursday's new record high. European stocks are down -0.72% to a 1-week low as German... Read More

Chart of the Day

Cooper Companies (COO) is the Barchart Chart of the Day.  The health care products company has a Trend Spotter buy signal, a Weighted Alpha of 34.54+ and gained 34.95% in the last year.
Read More

Brugler Ag Report

Today's Commentary

Corn futures closed the day 3 1/2 to 5 cents higher, as we head into the holiday weekend with some uncertainty about replanting and crop conditions in general. Markets will be open again on Tuesday. Over the past two weeks, corn futures have increase...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.